• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)德尔塔变异株对潜伏期、传播环境及疫苗效力的影响:法国一项全国性病例对照研究的结果

Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.

作者信息

Grant Rebecca, Charmet Tiffany, Schaeffer Laura, Galmiche Simon, Madec Yoann, Von Platen Cassandre, Chény Olivia, Omar Faïza, David Christophe, Rogoff Alexandra, Paireau Juliette, Cauchemez Simon, Carrat Fabrice, Septfons Alexandra, Levy-Bruhl Daniel, Mailles Alexandra, Fontanet Arnaud

机构信息

Institut Pasteur, Université de Paris, Emerging Diseases Epidemiology Unit, F-75015 Paris, France.

Sorbonne University, Paris, France.

出版信息

Lancet Reg Health Eur. 2022 Feb;13:100278. doi: 10.1016/j.lanepe.2021.100278. Epub 2021 Nov 26.

DOI:10.1016/j.lanepe.2021.100278
PMID:34849500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8616730/
Abstract

BACKGROUND

We aimed to assess the settings and activities associated with SARS-CoV-2 infection in the context of B.1.617.2 (Delta) variant circulation in France, as well as the protection against symptomatic Delta infection.

METHODS

In this nationwide case-control study, cases were SARS-CoV-2 infected adults recruited between 23 May and 13 August 2021. Controls were non-infected adults from a national representative panel matched to cases by age, sex, region, population density and calendar week. Participants completed an online questionnaire and multivariable logistic regression analysis was used to determine the association between acute SARS-CoV-2 infection and recent activity-related exposures, past history of SARS-CoV-2 infection, and COVID-19 vaccination.

FINDINGS

We did not find any differences in the settings and activities associated with Delta versus non-Delta infections and grouped them for subsequent analyses. In multivariable analysis involving 12634 cases (8644 Delta and 3990 non-Delta) and 5560 controls, we found individuals under 40 years and attending bars (aOR:1.9; 95%CI:1.6-2.2) or parties (aOR:3.4; 95%CI:2.8-4.2) to be at increased risk of infection. In those aged 40 years and older, having children attend daycare (aOR:1.9; 95%CI:1.1-3.3), kindergarten (aOR:1.6; 95%CI:1.2-2.1), primary school (aOR:1.4; 95%CI:1.2-1.6) or middle school (aOR:1.3; 95%CI:1.2-1.6) were associated with increased risk of infection. We found strong protection against symptomatic Delta infection for those with prior infection whether it was recent (2-6 months) (95%; 95%CI:90-97) or associated with one dose (85%; 95%CI:78-90) or two doses of mRNA vaccine (96%; 95%CI:87-99). For those without past infection, protection was lower with two doses of mRNA vaccine (67%; 95%CI:63-71).

INTERPRETATION

In line with other observational studies, we find reduced vaccine effectiveness against symptomatic Delta infections. The settings and activities at increased risk of infection indicate where efforts to reinforce individual and public health measures need to be concentrated.

摘要

背景

我们旨在评估在法国B.1.617.2(德尔塔)变种传播背景下与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染相关的环境和活动,以及针对有症状的德尔塔感染的防护情况。

方法

在这项全国性病例对照研究中,病例为2021年5月23日至8月13日期间招募的感染SARS-CoV-2的成年人。对照为来自全国代表性样本的未感染成年人,按年龄、性别、地区、人口密度和日历周与病例匹配。参与者完成一份在线问卷,并采用多变量逻辑回归分析来确定急性SARS-CoV-2感染与近期与活动相关的暴露、SARS-CoV-2感染既往史以及新冠病毒疫苗接种之间的关联。

结果

我们未发现与德尔塔感染和非德尔塔感染相关的环境和活动存在任何差异,并将它们合并进行后续分析。在涉及12634例病例(8644例德尔塔感染和3990例非德尔塔感染)和5560名对照的多变量分析中,我们发现40岁以下且去过酒吧(调整后比值比:1.9;95%置信区间:1.6 - 2.2)或参加派对(调整后比值比:3.4;95%置信区间:2.8 - 4.2)的个体感染风险增加。在40岁及以上人群中,孩子参加日托(调整后比值比:1.9;95%置信区间:1.1 - 3.3)、幼儿园(调整后比值比:1.6;95%置信区间:1.2 - 2.1)、小学(调整后比值比:1.4;95%置信区间:1.2 - 1.6)或中学(调整后比值比:1.3;95%置信区间:1.2 - 1.6)与感染风险增加相关。我们发现,无论既往感染是近期(2 - 6个月)(95%;95%置信区间:90 - 97),还是与一剂(85%;95%置信区间:78 - 90)或两剂信使核糖核酸(mRNA)疫苗相关,既往感染过的人对有症状的德尔塔感染都有很强的防护作用。对于没有既往感染的人,两剂mRNA疫苗的防护作用较低(67%;95%置信区间:63 - 71)。

解读

与其他观察性研究一致,我们发现针对有症状的德尔塔感染,疫苗效力有所降低。感染风险增加的环境和活动表明了加强个人和公共卫生措施的努力应集中在哪些方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b0/8841282/6f32d4bae4ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b0/8841282/5f00023ed216/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b0/8841282/6f32d4bae4ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b0/8841282/5f00023ed216/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01b0/8841282/6f32d4bae4ba/gr2.jpg

相似文献

1
Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)德尔塔变异株对潜伏期、传播环境及疫苗效力的影响:法国一项全国性病例对照研究的结果
Lancet Reg Health Eur. 2022 Feb;13:100278. doi: 10.1016/j.lanepe.2021.100278. Epub 2021 Nov 26.
2
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
3
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
4
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
5
Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study.法国与严重急性呼吸综合征冠状病毒2感染相关的暴露因素:一项全国性在线病例对照研究。
Lancet Reg Health Eur. 2021 Aug;7:100148. doi: 10.1016/j.lanepe.2021.100148. Epub 2021 Jun 7.
6
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
7
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.接种 COVID-19 疫苗与接种后时间和德尔塔变异株流行对有症状 SARS-CoV-2 感染的关联。
JAMA. 2022 Mar 15;327(11):1032-1041. doi: 10.1001/jama.2022.2068.
8
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
9
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.奥密克戎或德尔塔变异株感染及重症的 COVID-19 疫苗有效性评估。
JAMA Netw Open. 2022 Sep 1;5(9):e2232760. doi: 10.1001/jamanetworkopen.2022.32760.
10
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.原始毒株、B.1.1.7毒株以及B.1.351/P.1 新冠病毒谱系对两剂新冠mRNA疫苗有效性的影响:法国一项全国性病例对照研究的结果
Lancet Reg Health Eur. 2021 Sep;8:100171. doi: 10.1016/j.lanepe.2021.100171. Epub 2021 Jul 13.

引用本文的文献

1
Machine Learning and Probabilistic Approaches for Forecasting COVID-19 Transmission and Cases.用于预测新冠病毒传播和病例的机器学习与概率方法
medRxiv. 2025 Jun 24:2025.06.24.25330210. doi: 10.1101/2025.06.24.25330210.
2
Extracting circumstances of Covid-19 transmission from free text with large language models.使用大语言模型从自由文本中提取新冠病毒-19传播情况
Nat Commun. 2025 Jul 1;16(1):5836. doi: 10.1038/s41467-025-60762-w.
3
Effectiveness of a single COVID-19 mRNA vaccine dose in individuals with prior SARS-CoV-2 infection: a systematic review.

本文引用的文献

1
Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.2021 年 5 月至 6 月期间中国广东地区 SARS-CoV-2 Delta 变异株感染的传播动态和流行病学特征。
Euro Surveill. 2022 Mar;27(10). doi: 10.2807/1560-7917.ES.2022.27.10.2100815.
2
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
3
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.
一剂新冠病毒mRNA疫苗对既往感染过严重急性呼吸综合征冠状病毒2的个体的有效性:一项系统评价
Commun Med (Lond). 2025 May 3;5(1):151. doi: 10.1038/s43856-025-00882-y.
4
A Flexible Framework for Local-Level Estimation of the Effective Reproductive Number in Geographic Regions with Sparse Data.一种用于在数据稀疏的地理区域进行有效再生数的地方层面估计的灵活框架。
medRxiv. 2025 Mar 10:2024.11.06.24316859. doi: 10.1101/2024.11.06.24316859.
5
A flexible framework for local-level estimation of the effective reproductive number in geographic regions with sparse data.一种用于在数据稀疏的地理区域进行地方层面有效繁殖数估计的灵活框架。
BMC Med Res Methodol. 2025 Mar 18;25(1):73. doi: 10.1186/s12874-025-02525-1.
6
Evaluating the Effect of Public Health and Social Measures Under Rapid Changes in Population-level Immunity Against SARS-CoV-2: A Mathematical Modeling Study.评估在人群对新冠病毒免疫力快速变化情况下公共卫生和社会措施的效果:一项数学建模研究
Epidemiology. 2025 May 1;36(3):334-343. doi: 10.1097/EDE.0000000000001846. Epub 2025 Feb 3.
7
Correlates of Protection Against Symptomatic COVID-19: The CORSER 5 Case-Control Study.针对有症状的2019冠状病毒病的保护因素:CORSER 5病例对照研究。
Open Forum Infect Dis. 2025 Jan 8;12(1):ofaf006. doi: 10.1093/ofid/ofaf006. eCollection 2025 Jan.
8
A novel comparison framework for epidemiological strategies applied to age-based restrictions versus horizontal lockdowns.一种用于比较将基于年龄的限制措施与全面封锁应用于流行病学策略的新型框架。
Infect Dis Model. 2024 Jul 20;9(4):1301-1328. doi: 10.1016/j.idm.2024.07.002. eCollection 2024 Dec.
9
The changing contributory role to infections of work, public transport, shopping, hospitality and leisure activities throughout the SARS-CoV-2 pandemic in England and Wales.在英格兰和威尔士的整个新冠疫情期间,工作、公共交通、购物、酒店及休闲活动对感染的促成作用不断变化。
NIHR Open Res. 2023 Nov 3;3:58. doi: 10.3310/nihropenres.13443.1. eCollection 2023.
10
Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022.2020-2022 年法国专业场所、商店、共享交通和休闲活动中的 SARS-CoV-2 感染风险。
BMC Public Health. 2024 Sep 4;24(1):2411. doi: 10.1186/s12889-024-19651-y.
在挪威,报告的 SARS-CoV-2 德尔塔变异株和阿尔法变异株病例之间,住院风险无差异。
Int J Infect Dis. 2022 Feb;115:178-184. doi: 10.1016/j.ijid.2021.12.321. Epub 2021 Dec 11.
4
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性:一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.
5
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.卡塔尔:BNT162b2 疫苗对 SARS-CoV-2 感染的保护作用逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e83. doi: 10.1056/NEJMoa2114114. Epub 2021 Oct 6.
6
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
7
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.原始毒株、B.1.1.7毒株以及B.1.351/P.1 新冠病毒谱系对两剂新冠mRNA疫苗有效性的影响:法国一项全国性病例对照研究的结果
Lancet Reg Health Eur. 2021 Sep;8:100171. doi: 10.1016/j.lanepe.2021.100171. Epub 2021 Jul 13.
8
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
9
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.截至2021年6月,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的传播性增加及其在全球的传播情况。
Euro Surveill. 2021 Jun;26(24). doi: 10.2807/1560-7917.ES.2021.26.24.2100509.
10
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.苏格兰的新冠病毒德尔塔变异株:人口统计学、住院风险及疫苗有效性
Lancet. 2021 Jun 26;397(10293):2461-2462. doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.